Information Library
Results for: Product Development & Commercialization
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Reinventing Biopharma
White Paper — February 1, 2012
The biopharmaceutical industry today is facing a multifaceted “value challenge.” -
Harish Dave Discusses ASH 2011
Hear from the Experts — December 8, 2011
Harish Dave discusses the American Society of Hematology annual meeting. -
Quintiles Sells Minority Interest in Invida
Press Release — November 15, 2011 – Quintiles has sold its minority interest in Invida, an Asia Pacific commercial solutions joint venture, to the Italy-based Menarini Group, which is acquiring Invida in its entirety.
-
Multi-Channel Strategy
Brochure — November 9, 2011
Rethinking the Real Points of Power Today, pharmaceutical and biotech companies relying on a conventional communication strategy aimed squarely and exclusively at physicians find themselves -
Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.
Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).
-
Quintiles Acquires VCG & Associates and VCG Bio
Press Release — October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
-
Quintiles Names New Global Head of Clinical & Data Operations
Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.
-
Quintiles Addresses Key Considerations for Successful Biosimilar Development
Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.
-
An Integrated Approach to Biosimilar Development & Commercialization
White Paper — September 29, 2011
As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents. -
Improving Adherence
Case Study — September 21, 2011
Diabetes management education is especially critical to adherence and persistency among these newly diagnosed patients. But with health care professionals (HCPs) and long-term caregivers (LTCs) facing severely compressed schedules, there is limited time during appointments for these critical discussions.
